Stevanato Group S.P.A. (STVN)

Mar 11, 2025, 4:30 PM EDT - 6 weeks ago

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Mar 9, 2025, 2:37 PM EDT - 6 weeks ago

Stevanato: Ramping Syringe Demand, Buy Confirmed

Mar 6, 2025, 12:33 PM EST - 6 weeks ago

Stevanato Group S.p.A. (STVN) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 6:31 AM EST - 7 weeks ago

Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024

Feb 24, 2025, 4:02 PM EST - 2 months ago

Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025

Jan 7, 2025, 4:30 PM EST - 3 months ago

Stevanato Group to Present at Upcoming Investor Conference

Nov 13, 2024, 1:18 AM EST - 5 months ago

Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement

Nov 11, 2024, 6:32 AM EST - 5 months ago

Stevanato Group to Present at Upcoming Investor Conferences

Nov 5, 2024, 2:10 PM EST - 6 months ago

Stevanato Group S.p.A. (STVN) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 6:31 AM EST - 6 months ago

Stevanato Group Reports Financial Results for the Third Quarter of 2024

Oct 22, 2024, 4:30 PM EDT - 6 months ago

Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024

Oct 1, 2024, 6:30 AM EDT - 7 months ago

Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan

Sep 26, 2024, 7:04 AM EDT - 7 months ago

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”

Aug 10, 2024, 9:09 AM EDT - 9 months ago

Stevanato Group S.p.A. (STVN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 6:31 AM EDT - 9 months ago

Stevanato Group Reports Financial Results for the Second Quarter of 2024

Jul 25, 2024, 6:30 AM EDT - 9 months ago

Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 1, 2024, 7:30 AM EDT - 10 months ago

Stevanato Being Investigated on Behalf of Stevanato Group S.p.A. Investors.

Jun 11, 2024, 7:30 AM EDT - 11 months ago

An Investigation Has Commenced on Behalf of Stevanato Group S.p.A. Shareholders.

May 30, 2024, 5:00 AM EDT - 11 months ago

Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges

May 29, 2024, 2:16 AM EDT - 11 months ago

Stevanato: Destock Pressures, Long-Term Upside

May 28, 2024, 7:00 AM EDT - 11 months ago

Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro

May 24, 2024, 4:10 PM EDT - 11 months ago

Stevanato Group Announces Results of Annual General Meeting

May 11, 2024, 7:21 AM EDT - 1 year ago

Stevanato Group S.p.A. (STVN) Q1 2024 Earnings Call Transcript

May 9, 2024, 6:39 AM EDT - 1 year ago

Stevanato Group Reports Financial Results for the First Quarter of 2024

May 1, 2024, 4:30 PM EDT - 1 year ago

Stevanato Group to Present at the Bank of America Securities Healthcare Conference

Apr 25, 2024, 4:04 PM EDT - 1 year ago

Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024

Mar 29, 2024, 9:59 AM EDT - 1 year ago

International Companies Drive Diabesity Innovation

CTLT DXCM LLY NVO

Mar 26, 2024, 4:10 PM EDT - 1 year ago

Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares

Mar 21, 2024, 11:45 PM EDT - 1 year ago

Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares

Mar 20, 2024, 5:12 PM EDT - 1 year ago

Stevanato Group Announces Public Offering of Ordinary Shares

Mar 11, 2024, 5:05 PM EDT - 1 year ago

Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Mar 7, 2024, 2:41 PM EST - 1 year ago

Stevanato Group S.p.A. (STVN) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 6:30 AM EST - 1 year ago

Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023